JPH066173B2 - Blitz Chemotherapy Device - Google Patents
Blitz Chemotherapy DeviceInfo
- Publication number
- JPH066173B2 JPH066173B2 JP35456491A JP35456491A JPH066173B2 JP H066173 B2 JPH066173 B2 JP H066173B2 JP 35456491 A JP35456491 A JP 35456491A JP 35456491 A JP35456491 A JP 35456491A JP H066173 B2 JPH066173 B2 JP H066173B2
- Authority
- JP
- Japan
- Prior art keywords
- signal
- trigger signal
- electrocardiographic
- electrocardiographic signal
- voltage pulse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002512 chemotherapy Methods 0.000 title claims description 9
- 230000001360 synchronised effect Effects 0.000 claims description 11
- 230000008602 contraction Effects 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 6
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 claims 2
- 201000011510 cancer Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 206010061592 cardiac fibrillation Diseases 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002600 fibrillogenic effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 208000010496 Heart Arrest Diseases 0.000 description 2
- 230000000973 chemotherapeutic effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000235 effect on cancer Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Electrotherapy Devices (AREA)
Description
【0001】[0001]
【産業上の利用分野】この発明は悪性腫瘍の化学療法を
行うに際し、悪性腫瘍の両側に電極を配置しこれに高電
圧パルスを印加することにより、化学療法の効果を向上
させ得る電撃化学療法を安全確実に実行するための装置
に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to electric shock chemotherapy which can improve the effect of chemotherapy by arranging electrodes on both sides of the malignant tumor and applying a high voltage pulse to the electrodes when performing chemotherapy for malignant tumor. The present invention relates to a device for safely and reliably executing.
【0002】[0002]
【従来の技術】悪性腫瘍の化学療法は、一般に副作用が
大きく癌細胞に有効に作用しても同じに正常細胞にも悪
影響を与える結果となり、身体の消耗を招き充分な治療
効果を期待できない。一方副作用の少ない薬物では、癌
細胞への効果も殆んど期待できなかった。ところがラッ
ト、マウスを使った実験では、化学療法を行うに際し、
腫瘍の両側に電極を配置しこれに高電圧パルスを印加す
ると、薬物のみではほとんど効果のなかった各種の抗癌
剤投与の場合においても、顕著な腫瘍の縮小が認められ
ている。2. Description of the Related Art Chemotherapy for malignant tumors generally has a large number of side effects, but even if they effectively act on cancer cells, they also adversely affect normal cells, resulting in wasting of the body, and a sufficient therapeutic effect cannot be expected. On the other hand, a drug with few side effects could hardly be expected to have an effect on cancer cells. However, in experiments using rats and mice, when giving chemotherapy,
When electrodes are placed on both sides of a tumor and a high-voltage pulse is applied to the electrodes, a marked reduction in tumor is observed even in the case of administration of various anticancer agents, which had little effect with the drug alone.
【0003】このため本出願人が先に提案した特開平3
−236861号公報に記載のものが周知である。For this reason, the applicant of the present invention has previously proposed JP-A-3
The one described in Japanese Patent No. 236861 is well known.
【0004】この従来例は心臓の収縮に伴って発生する
心電信号Cをピックアップするための心電信号検出部1
と、この心電信号検出部1 から検出した心電信号Cに同
期したトリガー信号Fを発生するトリガー信号発生部2
と、このトリガー信号発生部2 から得たトリガー信号F
に基づいて患部細胞組織を挟んで対設した対をなす電極
P1,P2 間に高電圧パルスHを出力する高圧パルス発生
部3 とをそれぞれ具備してなる電撃化学療法の実行装置
である。In this conventional example, an electrocardiographic signal detection unit 1 for picking up an electrocardiographic signal C generated with the contraction of the heart.
And a trigger signal generator 2 for generating a trigger signal F synchronized with the electrocardiographic signal C detected by the electrocardiographic signal detector 1.
And the trigger signal F obtained from this trigger signal generator 2
And a high-voltage pulse generator 3 for outputting a high-voltage pulse H between electrodes P1 and P2 that are paired with each other with the affected cell tissue sandwiched therebetween.
【0005】[0005]
【発明が解決しようとする課題】そしてこの実行時には
前記電極P1,P2 に誤操作または誤動作によって不用意
に高圧パルスが出力しないよう、通常は手動リレースイ
ッチで高圧ラインを大地に接地して、万一高圧パルスが
高圧ライン側に混入しても、大地に流れて生体には印加
しないようにしてある。そして高圧インパルスを出力す
るには安全用リレー回路の接地を手動で開放した後、心
電R波に同期させて高圧インパルスを発生する。In order to prevent careless operation or malfunction of the electrodes P1 and P2 from inadvertently outputting a high-voltage pulse, the high-voltage line is normally grounded to the ground by a manual relay switch. Even if the high-voltage pulse mixes into the high-voltage line side, it flows to the ground and is not applied to the living body. To output a high-voltage impulse, the safety relay circuit is manually opened to ground, and then a high-voltage impulse is generated in synchronization with the R wave of the electrocardiogram.
【0006】発生後は上記高圧ラインを手動操作で接地
してしまうことにより安全が確保できる。すなわち図3
に示すようにまず安全スイッチを手動で開き、出力可能
な状態にし、この後スタートボタンを押してスタート信
号Dを発生する。After the occurrence, safety can be secured by manually grounding the high voltage line. That is, FIG.
First, the safety switch is manually opened to enable output, as shown in FIG. 3, and then the start button is pressed to generate the start signal D.
【0007】スタート信号Dが発生した後、最初の心電
信号R波に同期してトリガー信号Fが発生し、これによ
って高圧トリガー回路をスイッチングして高圧インパル
スHを出力する。After the start signal D is generated, the trigger signal F is generated in synchronism with the first electrocardiographic signal R wave, whereby the high voltage trigger circuit is switched and the high voltage impulse H is output.
【0008】この従来例で心電同期をとろうとすると以
下に述べる問題がある。つまり心電信号は1mv位で極
めて微弱で外来ノイズの影響を受けやすい。安全スイッ
チが閉じた状態では装置の出力ラインはいずれも接地済
の状態となっているから心電信号は安全にピックアップ
できる。[0008] In this conventional example, there are the following problems when trying to achieve electrocardiographic synchronization. That is, the electrocardiographic signal is extremely weak at about 1 mv and is easily affected by external noise. When the safety switch is closed, the output lines of the device are all grounded, so the electrocardiographic signal can be safely picked up.
【0009】ところが安全スイッチを開いて高圧出力ラ
インがアースから浮上った状態ではノイズが混入するよ
うになり、ノイズは治療用電極を通じて治療対象(心電
検出の対象でもある)生体に混入する。However, when the safety switch is opened and the high-voltage output line floats above the ground, noise is mixed, and the noise is mixed into the living body to be treated (also the target of electrocardiographic detection) through the treatment electrode.
【0010】これらの外来ノイズは時として心電信号の
数倍のレベルに達し、心電信号の検出が不可能になる場
合が生じる結果、的確な電撃化学療法が実行できない場
合が多発してしまうという大きな問題点のほかに、操作
性の面でも煩わしいという問題点が有った。These external noises sometimes reach a level several times higher than that of the electrocardiographic signal, and the electrocardiographic signal cannot be detected. As a result, accurate electric shock chemotherapy cannot often be performed. In addition to the big problem, there was a problem that it was troublesome in terms of operability.
【0011】この発明は前記した各問題点を除去するた
めに、悪性腫瘍の電撃化学療法を行うに際し、悪性腫瘍
の両側に電極を配置しこれに心電信号に同期した高電圧
パルスを印加する直前から所定時間だけ高圧出力ライン
の接地を解除することにより、外来ノイズの混入を防ぎ
つつ心臓に悪影響を与えずにしかも安全かつ確実に電撃
化学療法の効果を向上させ得る実行装置を提供すること
を目的とする。In order to eliminate the above-mentioned problems, the present invention arranges electrodes on both sides of a malignant tumor and applies a high voltage pulse synchronized with an electrocardiographic signal to the malignant tumor when performing electrochemotherapy of the malignant tumor. To provide an execution device capable of safely and surely improving the effect of electrochemotherapy by preventing the external noise from being mixed in and without adversely affecting the heart by releasing the grounding of the high-voltage output line for a predetermined time from immediately before. With the goal.
【0012】[0012]
【課題を解決するための手段】上記したこの発明の目的
は、心臓の収縮に伴って発生する心電信号をピックアッ
プするための心電信号検出部と、この心電信号検出部か
ら検出した心電信号に同期したトリガー信号を発生する
トリガー信号発生部と、このトリガー信号発生部から得
たトリガー信号に基づいて患部細胞組織を挟んで対設し
た対をなす電極間に高電圧パルスを出力する高圧パルス
発生部とをそれぞれ具備し、前記高圧パルス発生部の高
圧出力ラインを接地する安全回路を設けてこの回路の接
地接片を前記トリガー信号に同期して所定時間だけ解放
可能に構成することで達成できる。The above-mentioned object of the present invention is to detect an electrocardiographic signal for picking up an electrocardiographic signal generated by the contraction of the heart, and a heart detected by the electrocardiographic signal detecting section. A high-voltage pulse is output between a trigger signal generator that generates a trigger signal synchronized with the electric signal and electrodes that form a pair of electrodes that sandwich the affected tissue based on the trigger signal obtained from the trigger signal generator. A high-voltage pulse generator, a safety circuit for grounding the high-voltage output line of the high-voltage pulse generator, and a grounding contact of the circuit being releasable for a predetermined time in synchronization with the trigger signal. Can be achieved with.
【0013】[0013]
【作用】この発明による電撃化学療法の実行装置は悪性
腫瘍の治療法の1つで、抗癌剤を投与後に病巣部に3000
〜7000Vのインパルスを印加して治療を行う。この際心
臓への悪影響を避けるため心電R波に同期させて高圧イ
ンパルスを印加することができる。The electric shock chemotherapeutic device according to the present invention is one of the treatment methods for malignant tumors.
Treatment is performed by applying an impulse of ˜7000V. At this time, in order to avoid adverse effects on the heart, the high-voltage impulse can be applied in synchronization with the electrocardiographic R wave.
【0014】すなわちこの発明の基本的な動作(作用)
は心臓筋肉の収縮に伴って発生する心電信号中のR波に
よる心電信号を心電信号検出部で検出するとともに、こ
の心電信号と操作パネルの操作で生じたスタート信号と
のアンドゲート出力パルス、つまり操作パネルからのス
タート信号持続期間中に生じた前記心電信号に同期して
得たトリガー信号に基づいて高圧出力ラインを接地する
安全回路を所定時間だけ解放している間に患部細胞組織
を挟んで対設した対をなす電極間に高圧パルス発生部か
らの3〜7KV程度の高圧パルスを心臓の電気的不感時
間帯に出力することで、心臓の停止や細動の発生を厳重
に防ぎながら電撃化学療法を実行できる。That is, the basic operation (action) of the present invention
Detects the electrocardiographic signal due to the R wave in the electrocardiographic signal generated by the contraction of the heart muscle with the electrocardiographic signal detection unit, and AND gates the electrocardiographic signal and the start signal generated by the operation of the operation panel. The affected part while the safety circuit for grounding the high-voltage output line based on the output pulse, that is, the trigger signal obtained in synchronization with the electrocardiographic signal generated during the start signal duration from the operation panel is released for a predetermined time. By outputting a high-voltage pulse of about 3 to 7 KV from the high-voltage pulse generator between the pair of electrodes sandwiching the cell tissue in between during the electrical dead time of the heart, the occurrence of cardiac arrest and fibrillation can be prevented. Can perform blitz chemotherapy while strictly preventing it.
【0015】そして常に生体や高圧出力ラインに生じて
いる外来誘導ノイズを高圧パルスの生体印加時以外の大
部分の時間帯に前記安全回路で接地除去することがで
き、心電信号を間違いなくピックアップできるから、不
要時に発生する危険かつ無用な高圧インパルスの生体印
加を無くすることができる。The external inductive noise that is constantly generated in the living body or the high-voltage output line can be grounded and removed by the safety circuit during most of the time except when the high-voltage pulse is applied to the living body, and the electrocardiographic signal is surely picked up. Therefore, it is possible to eliminate the dangerous and useless application of the high-voltage impulse to the living body that occurs when unnecessary.
【0016】[0016]
【実施例】実施例について図面を参照して説明する。先
ずこの発明の基本構成は図1、図2に示すように、心臓
の収縮に伴って発生する心電信号Cをピックアップする
ための電極Aを有する心電信号検出部1 と、この心電信
号検出部1 から検出した心電信号Cに同期し、かつ操作
パネルBによるスタート信号Dによりトリガー信号Fを
発生するアンドゲート回路内装のトリガー信号発生部2
とを備える。EXAMPLES Examples will be described with reference to the drawings. First, as shown in FIGS. 1 and 2, the basic configuration of the present invention is an electrocardiographic signal detection unit 1 having an electrode A for picking up an electrocardiographic signal C generated with the contraction of the heart, and the electrocardiographic signal. A trigger signal generator 2 with an AND gate circuit, which is synchronized with the electrocardiographic signal C detected by the detector 1 and generates a trigger signal F by a start signal D from the operation panel B.
With.
【0017】そしてこのトリガー信号発生部2 から得た
前記心電信号Cに同期したトリガー信号Fに基づいて患
部細胞組織を挟んで対設した対をなす電極P1,P2 間に
高電圧パルスHを出力する高圧パルス発生部3 とをそれ
ぞれ具備する。Then, based on the trigger signal F synchronized with the electrocardiographic signal C obtained from the trigger signal generator 2, a high voltage pulse H is applied between a pair of electrodes P1 and P2 oppositely sandwiching the affected tissue. And a high-voltage pulse generator 3 for outputting.
【0018】また前記高圧パルス発生部3 の高圧出力ラ
インを接地する安全回路4 を設けてこの回路4 内の常閉
の接地接片 4eを前記トリガー信号Fに同期して所定時
間だけ解放可能に構成する。Further, a safety circuit 4 for grounding the high-voltage output line of the high-voltage pulse generator 3 is provided so that the normally-closed grounding contact piece 4e in the circuit 4 can be released for a predetermined time in synchronization with the trigger signal F. Constitute.
【0019】すなわち安全回路4 は図1における点線枠
内に示すように、前記トリガー信号発生部2 に生じた前
記トリガー信号Fと操作パネルBからのスタート信号D
とをそれぞれアンド回路 4aの入力側に供給印加可能に
すると共に、そのアンド出力の時間幅を次段のワンショ
ットマルチバイブレータなどの信号時間幅延長回路 4b
で所望の時間幅となし、ドライブ回路 4cを経てリレー
コイル 4dを励磁することで、その常閉の接地接片 4e
を高圧バルスの生体印加時に解放するように構成してあ
る。That is, the safety circuit 4 has the trigger signal F generated in the trigger signal generator 2 and the start signal D from the operation panel B as shown in the dotted frame in FIG.
Can be supplied and applied to the input side of the AND circuit 4a, and the time width of the AND output can be applied to the signal time width extension circuit 4b such as the one-shot multivibrator in the next stage.
With the desired time width, the relay coil 4d is excited through the drive circuit 4c, and the normally-closed grounding contact 4e.
Is configured to be released when a high-pressure pulse is applied to the living body.
【0020】心電信号検出部1 は周知の電極Aでピック
アップした心電信号の中からR波だけを選択的に検出
し、図2に示すような心電信号Cを出力する。トリガー
信号発生部2 は操作パネルBからのスタート信号Dが加
わった直後の心電信号Cに同期した図2のようなトリガ
ー信号Fを出力する。高圧パルス発生部3 はトリガー信
号Fに同期した図2のような高電圧パルスHを発生す
る。The electrocardiographic signal detector 1 selectively detects only the R wave from the electrocardiographic signals picked up by the well-known electrode A, and outputs an electrocardiographic signal C as shown in FIG. The trigger signal generator 2 outputs a trigger signal F as shown in FIG. 2 synchronized with the electrocardiographic signal C immediately after the start signal D from the operation panel B is applied. The high voltage pulse generator 3 generates a high voltage pulse H synchronized with the trigger signal F as shown in FIG.
【0021】P1,P2 は治療用電極であり、癌組織を挟
んでその両側に対向配置してある。P1 and P2 are therapeutic electrodes, which are arranged on opposite sides of the cancer tissue so as to face each other.
【0022】なお3つの心電信号の中からR波だけを選
択的に検出する手段としては、Q波、S波よりもR波の
電圧振幅が大きいことを利用して例えば周知のスライサ
回路等により設定電圧レベルよりも大きいR波による心
電信号Cだけを検出できる。As a means for selectively detecting only the R wave from the three electrocardiographic signals, the fact that the voltage amplitude of the R wave is larger than that of the Q wave and the S wave is used, for example, a well-known slicer circuit or the like. Thus, it is possible to detect only the electrocardiographic signal C due to the R wave that is larger than the set voltage level.
【0023】またトリガー信号Fに同期した高電圧パル
スHを得るには、巻線比が1:25程度に設定した昇圧
トランスの1次側巻線に流れる電流をパワートランジス
タ等のスイッチング素子で上記トリガー信号Fに同期し
て断続することで、2次側高圧巻線から5〜10KV程
度の高電圧パルスHを心電信号Cに同期させて図2に示
すように得ることができる。Further, in order to obtain the high voltage pulse H synchronized with the trigger signal F, the current flowing through the primary winding of the step-up transformer whose winding ratio is set to about 1:25 is switched by the switching element such as a power transistor. By intermittently synchronizing with the trigger signal F, a high voltage pulse H of about 5 to 10 KV can be obtained from the secondary high voltage winding in synchronization with the electrocardiographic signal C as shown in FIG.
【0024】なお図2において心電信号Cは心臓の拍動
毎に1つのパルスとなって検出するようにしてある。ト
リガー信号Fはスタート信号Dが加わった直後の心電信
号Cに同期して出力するようにしてある。In FIG. 2, the electrocardiographic signal C is detected as one pulse for each heartbeat. The trigger signal F is output in synchronization with the electrocardiographic signal C immediately after the start signal D is applied.
【0025】操作パネルBの操作タイミングにより、も
しスタート信号Dが心電信号Cの領域で印加され始めた
ときにはこのスタート信号と心電信号とのアンド出力パ
ルスは生ぜず、次の心電信号Cに同期してトリガー信号
Fを出力するようにしてある。Depending on the operation timing of the operation panel B, if the start signal D is applied in the area of the electrocardiographic signal C, an AND output pulse between the start signal and the electrocardiographic signal does not occur, and the next electrocardiographic signal C is generated. The trigger signal F is output in synchronism with.
【0026】また安全回路4 内の常閉接片 4eは図2の
ようにトリガー信号Fに同期させて開くようにしてい
る。このようにするとトリガー信号Fが発生するまでは
生体は大地に接地されていて外来ノイズが混入すること
がなく、安定に心電信号Cをピックアップできる。トリ
ガー信号発生後には外来ノイズが混入するが、心電信号
Cをピックアップする目的が心電信号Cに同期したトリ
ガー信号Fを得ることにあるので、トリガー信号発生後
の外来ノイズ混入は動作に支障を来たさない。The normally-closed contact piece 4e in the safety circuit 4 is opened in synchronization with the trigger signal F as shown in FIG. In this way, the living body is grounded to the ground until the trigger signal F is generated, external noise is not mixed, and the electrocardiographic signal C can be stably picked up. Although the external noise is mixed after the trigger signal is generated, the purpose of picking up the electrocardiographic signal C is to obtain the trigger signal F synchronized with the electrocardiographic signal C. Therefore, mixing the external noise after the trigger signal is generated impairs the operation. Don't come
【0027】安全回路4 内の接地用の例えばリレーは機
構部品なので、動作に10〜20msecを要する。高
圧インパルスの出力は安全回路4 が完全に開になった時
でなければならない。それ以前に出力すると短絡状態の
回路に高電圧を印加したことになり、出力回路の焼損な
どのトラブルをまねく。Since a grounding relay, for example, in the safety circuit 4 is a mechanical component, it takes 10 to 20 msec to operate. The output of the high voltage impulse shall be when the safety circuit 4 is fully open. If it is output before that, it means that a high voltage is applied to the short-circuited circuit, which causes a trouble such as burnout of the output circuit.
【0028】実際には高圧インパルス発生を周知の遅延
回路等により、図2のようにトリガー信号Fから30〜
40ms後に設定している。Actually, the generation of the high-voltage impulse is made 30 to 30 times from the trigger signal F by a well-known delay circuit or the like as shown in FIG.
It is set after 40 ms.
【0029】この結果高圧インパルスHは心電信号R波
から30〜40ms遅れることになるが、この程度の遅
れは生体に悪影響を及ぼすことはない。As a result, the high-voltage impulse H is delayed from the R wave of the electrocardiographic signal by 30 to 40 ms, but such a delay does not adversely affect the living body.
【0030】以上要するにこの発明は、心臓筋肉の収縮
に伴って発生する心電信号中のR波による心電信号を心
電信号検出部で検出するとともに、この心電信号と操作
パネルの操作で生じたスタート信号とのアンドゲート出
力パルス、つまり操作パネルからのスタート信号持続期
間中に前記心電信号に同期して得たトリガー信号に基づ
いて患部細胞組織を挟んで対設した対をなす電極間に高
圧パルス発生部からの高電圧パルスを心臓の電気的不感
時間帯に出力し、かつこの出力時を含む所定時間だけ高
圧出力ラインの接地を解除することで生体患部に高圧イ
ンパルスを印加して心臓の停止や細動の発生を厳重に防
ぎながら心電信号ピックアップに有害な外来誘導ノイズ
を遮断しつつ電撃化学療法を安全に実行することができ
る。In summary, according to the present invention, the electrocardiographic signal detected by the R wave in the electrocardiographic signal generated by the contraction of the heart muscle is detected by the electrocardiographic signal detecting section, and the electrocardiographic signal and the operation panel are operated. An AND gate output pulse with the generated start signal, that is, a pair of electrodes opposed to each other across the affected tissue based on the trigger signal obtained in synchronization with the electrocardiographic signal during the start signal duration from the operation panel During this period, a high-voltage pulse from the high-voltage pulse generator is output during the electrical dead time of the heart, and the high-voltage output line is released for a predetermined time including this output to apply a high-voltage impulse to the affected part of the living body. It is possible to safely carry out electrochemotherapy while blocking the outbreak of inductive noise that is harmful to the ECG signal pickup while strictly preventing the occurrence of cardiac arrest and fibrillation.
【0031】[0031]
【発明の効果】この発明は以上説明したように構成した
ので、以下に記載の効果を奏する。心臓の収縮に伴って
発生する心電信号に同期したトリガー信号に基づいて患
部細胞組織を挟んで対設した対をなす電極間に高圧パル
ス発生部からの高電圧パルスを出力することで、心臓の
停止や細動の発生を充分確実に防ぎながら電撃化学療法
を安全に実行することができ、特にこの発明では常に生
体や高圧出力ラインに生じている外来誘導ノイズを高圧
パルスの生体印加時以外の大部分の時間帯に前記安全回
路で接地除去することができ、心電信号を間違いなくピ
ックアップできるから、不要時に外来ノイズにより誤っ
て発生する危険かつ無用な高圧インパルスの生体印加を
無くすることができるという卓効が有る。Since the present invention is constructed as described above, it has the following effects. By outputting a high-voltage pulse from the high-voltage pulse generator between the paired electrodes that sandwich the affected tissue based on the trigger signal synchronized with the electrocardiographic signal generated with the contraction of the heart, the heart It is possible to safely carry out shock chemotherapeutic therapy while sufficiently preventing the occurrence of stoppage and fibrillation of the patient, and in particular, in the present invention, the external inductive noise that is always generated in the living body or the high voltage output line is applied except when the high pressure pulse is applied to the living body. Since the safety circuit can remove the ground during most of the time, and the ECG signal can be picked up without fail, it is possible to eliminate the dangerous and useless application of high-voltage impulse that is accidentally generated by external noise when unnecessary. There is a great effect that you can.
【図1】この発明実施例の電気的系統回路図FIG. 1 is an electrical system circuit diagram of an embodiment of the present invention.
【図2】図1のものの動作説明図FIG. 2 is an explanatory diagram of the operation of FIG.
【図3】従来のものの動作説明図FIG. 3 is an operation explanatory diagram of a conventional one.
1 心電信号検出部 2 トリガー信号発生部 3 高圧パルス発生部 4 安全回路 4a 接地接片 A 電極 B 操作パネル C 心電信号 D スタート信号 F トリガー信号 H 高電圧パルス 1 ECG signal detector 2 Trigger signal generator 3 High voltage pulse generator 4 Safety circuit 4a Grounding contact A Electrode B Operation panel C ECG signal D Start signal F Trigger signal H High voltage pulse
Claims (1)
をピックアップするための心電信号検出部1 と、この心
電信号検出部1 から検出した心電信号Cに同期したトリ
ガー信号Fを発生するトリガー信号発生部2 と、このト
リガー信号発生部2 から得たトリガー信号Fに基づいて
患部細胞組織を挟んで対設した対をなす電極P1,P2 間
に高電圧パルスHを出力する高圧パルス発生部3 とをそ
れぞれ具備し、前記高圧パルス発生部3 の高圧出力ライ
ンを接地する安全回路4 を設けてこの回路4 の接地接片
4eを前記トリガー信号Fに同期して所定時間だけ解放
可能に構成してなる電撃化学療法の実行装置。1. An electrocardiographic signal C generated with the contraction of the heart.
From the electrocardiographic signal detection unit 1 for picking up the electrocardiogram, the trigger signal generation unit 2 that generates the trigger signal F synchronized with the electrocardiographic signal C detected by the electrocardiographic signal detection unit 1, and the trigger signal generation unit 2 A high-voltage pulse generator 3 for outputting a high-voltage pulse H between electrodes P1 and P2 forming a pair on opposite sides of the affected cell tissue based on the obtained trigger signal F. Provide a safety circuit 4 that grounds the high-voltage output line of the
An apparatus for executing electric shock chemotherapy, which is configured so that 4e can be released for a predetermined time in synchronization with the trigger signal F.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35456491A JPH066173B2 (en) | 1991-12-19 | 1991-12-19 | Blitz Chemotherapy Device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35456491A JPH066173B2 (en) | 1991-12-19 | 1991-12-19 | Blitz Chemotherapy Device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05168722A JPH05168722A (en) | 1993-07-02 |
| JPH066173B2 true JPH066173B2 (en) | 1994-01-26 |
Family
ID=18438410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP35456491A Expired - Fee Related JPH066173B2 (en) | 1991-12-19 | 1991-12-19 | Blitz Chemotherapy Device |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH066173B2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006087486A (en) * | 2004-09-21 | 2006-04-06 | Toshiyasu Yamamoto | Electric stimulation device |
| JP4980167B2 (en) * | 2007-08-01 | 2012-07-18 | 伊藤超短波株式会社 | Potential therapy device |
| JP5464924B2 (en) * | 2009-06-26 | 2014-04-09 | オリンパス株式会社 | Heart treatment equipment |
| JP2016086969A (en) * | 2014-10-31 | 2016-05-23 | オリンパス株式会社 | Nerve stimulation device and control method thereof |
| US11065047B2 (en) * | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
-
1991
- 1991-12-19 JP JP35456491A patent/JPH066173B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05168722A (en) | 1993-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115397348B (en) | Systems, apparatus, and methods for protecting electronic components from high-power noise caused by high-voltage pulses. | |
| US3968802A (en) | Cautery protection circuit for a heart pacemaker | |
| US5814086A (en) | Perex respiratory system stimulation upon tachycardia detection | |
| JP2815299B2 (en) | Device for determining defibrillation threshold | |
| JP2024015384A (en) | Systems, devices, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation | |
| US11931090B2 (en) | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses | |
| CA2129063A1 (en) | Method and apparatus for phase related cardiac defibrillation | |
| KR910005915B1 (en) | Electrodes for defibrillators (defibrillator electrodes) | |
| JP2008523950A5 (en) | ||
| US3661158A (en) | Atrio-ventricular demand pacer with atrial stimuli discrimination | |
| EP1404410B1 (en) | Defibrillator system | |
| GB2225534A (en) | Electrosurgical apparatus | |
| JPH066173B2 (en) | Blitz Chemotherapy Device | |
| JPS6214299B2 (en) | ||
| JPH066172B2 (en) | Blitz Chemotherapy Device | |
| JP6942801B2 (en) | A device that terminates or eliminates rotational electrical activity in the heart tissue | |
| JPH06178818A (en) | Transplantable cardiac fibrillation removing equipment | |
| US7203544B2 (en) | Detection of evoked post-stimulation potentials, in particular atrial potentials in an active implantable medical device such as cardiac pacemaker, defribillator, cardiovertor or multisite device | |
| JPH0613752Y2 (en) | Current-carrying electrode part in the device for performing electric shock chemotherapy | |
| Green et al. | DANGER LEVELS OF SHORT (1mSec to 15mSec) ELECTRICAL SHOCKS FROM 50Hz SUPPLY | |
| JPS6150629B2 (en) | ||
| FI65371C (en) | APPARAT FOER ELEKTRISK ARKOS | |
| JPS5917360A (en) | Implantable cardiac minute movement removing device using bipolar sensor means and telemetry means | |
| Topyła et al. | The impact of electromagnetic fields and other physical factors used in medicine on cardiac implantable electronic devices | |
| AU2002345334A1 (en) | Defibrillator system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19940809 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |